TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15223899

Group type: EXPERIMENTAL
Intervention: FTY720 0.25 mg
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: FTY720 0.5 mg
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: FTY720 1.0 mg
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: FTY720 2.5 mg
Number of subjects: 208

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 208
Study: 11812393

Group type: EXPERIMENTAL
Intervention: Repressors
Number of subjects: 41

Group type: COMPARATOR
Intervention: 'Truly' low anxious participants
Number of subjects: 41

Group type: COMPARATOR
Intervention: Moderately high anxious participants
Number of subjects: 41
Study: 9569474

Group type: EXPERIMENTAL
Intervention: Two doses of recombinant hepatitis B vaccine (10 micrograms or 20 micrograms of HBsAg per dose), administered 6 months apart
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Booster dose of vaccine given 2 years later
Number of subjects: 0
Study: 7922851

Group type: EXPERIMENTAL
Intervention: Computerized colour vision tests (City University Colour Vision Test, Ishihara plates, American Optical Hardy‐Rand‐Rittler plates)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Computerized colour vision tests
Number of subjects: 32
Study: 2967032

Group type: EXPERIMENTAL
Intervention: methylprednisolone and chlorambucil for 6 months
Number of subjects: 39

Group type: COMPARATOR
Intervention: untreated patients
Number of subjects: 39
Study: 31428894

Group type: EXPERIMENTAL
Intervention: Rikkunshito (RKT) 7.5 g/day for 14 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no RKT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rikkunshito (RKT)
Number of subjects: 40
Study: 30321854

Group type: EXPERIMENTAL
Intervention: Customized foot orthoses
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual footwear (control)
Number of subjects: 72
Study: 28615257

Group type: EXPERIMENTAL
Intervention: Iron ingot
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Iron supplement (18 mg/d)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Iron supplement
Number of subjects: 340
Study: 26033286

Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study: 24151693

Group type: EXPERIMENTAL
Intervention: Video information
Number of subjects: 128

Group type: COMPARATOR
Intervention: Verbal information
Number of subjects: 128
Study: 20966119

Group type: EXPERIMENTAL
Intervention: New equations to estimate creatinine excretion rate (CER) with serum phosphorus
Number of subjects: 2466

Group type: EXPERIMENTAL
Intervention: New equations to estimate creatinine excretion rate (CER) without serum phosphorus
Number of subjects: 2466

Group type: COMPARATOR
Intervention: Existing equations to estimate creatinine excretion rate (CER)
Number of subjects: 2466
Study: 18434157

Group type: EXPERIMENTAL
Intervention: fatigue of the plantar‐flexor muscles
Number of subjects: 10

Group type: COMPARATOR
Intervention: no‐fatigue
Number of subjects: 10
Study: 17000412

Group type: EXPERIMENTAL
Intervention: EYEPORT training (10 minutes per day, 6 days a week for 3 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No-train control condition (3 weeks)
Number of subjects: 31
Study: 14551493

Group type: EXPERIMENTAL
Intervention: HRRV with no S/B but with prefeeding
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: HRRV plus 1 of 3 different concentrations/volumes of S/B
Number of subjects: 731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: S/B vaccine groups
Number of subjects: 731
Study: 10900525

Group type: EXPERIMENTAL
Intervention: Short-term individual dynamic psychotherapy (form 1)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Short-term individual dynamic psychotherapy (form 2)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Patient ratings of the alliance and technique
Number of subjects: 144
Study: 8823332

Group type: COMPARATOR
Intervention: Radiotherapy (RT) and fluorouracil (5-FU)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT), fluorouracil (5-FU), and mitomycin (MMC)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Salvage chemoradiation (CR)
Number of subjects: 291
Study: 1418102

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg twice daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg twice daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lovastatin 80 mg twice daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg twice daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg twice daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg twice daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 23

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 23
Study: 3883879

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 0
Study: 31182401

Group type: EXPERIMENTAL
Intervention: Self-reported height, weight, and BMI
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-reported waist circumference
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-reported blood pressure (BP)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-reported hypertension classification
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-measurements of BMI and diastolic BP
Number of subjects: 200
Study: 29242283

Group type: EXPERIMENTAL
Intervention: BEZ235 400 mg twice daily
Number of subjects: 62

Group type: COMPARATOR
Intervention: Everolimus 10 mg once daily
Number of subjects: 62
Study: 27074806

Group type: EXPERIMENTAL
Intervention: 12-week multidisciplinary team care programme including a hand function treatment module
Number of subjects: 53

Group type: COMPARATOR
Intervention: Regular care (control group)
Number of subjects: 53
Study: 25022113

Group type: EXPERIMENTAL
Intervention: Jin's three-needle therapy (acupuncture)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Desloratadine oral suspension (5 mg once a day for 20 days)
Number of subjects: 66
Study: 22545252

Group type: EXPERIMENTAL
Intervention: Topical nystatin 4 times/day for 14 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Microwave denture disinfection (650 W for 3 minutes) 3 times/week for 14 days
Number of subjects: 40
Study: 20673621

Group type: EXPERIMENTAL
Intervention: Supervision
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: No supervision
Number of subjects: 122

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 122
Study: 17400142

Group type: EXPERIMENTAL
Intervention: Qigong
Number of subjects: 20
Study: 16264158

Group type: EXPERIMENTAL
Intervention: HPV DNA testing with cryotherapy for positive HPV results
Number of subjects: 6555

Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA) with cryotherapy for positive VIA results
Number of subjects: 6555

Group type: COMPARATOR
Intervention: Delayed evaluation (control group)
Number of subjects: 6555
Study: 11876709

Group type: EXPERIMENTAL
Intervention: H. pylori eradication treatment (1-week omeprazole-based triple therapy, followed by 7-week omeprazole)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Omeprazole alone (8-week omeprazole)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Uninfected patients (control group)
Number of subjects: 40
Study: 10453583

Group type: EXPERIMENTAL
Intervention: Acupuncture with vibrating shallow insertion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional electroacupuncture method
Number of subjects: 80
Study: 8800852

Group type: EXPERIMENTAL
Intervention: Central one third patellar tendon
Number of subjects: 10

Group type: COMPARATOR
Intervention: Residual patellar tendon
Number of subjects: 10
Study: 2184527

Group type: EXPERIMENTAL
Intervention: Combination tablet (RHZ), 5 tablets per day on weekdays for 100 treatment-days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Four-drug regimen (RHZS) (streptomycin, rifampicin, isoniazid and pyrazinamide)
Number of subjects: 150
Study: 376950

Group type: EXPERIMENTAL
Intervention: Treatment 1: Actinomycin-D (Act-D), 0.01 mg/kg IV, days 1-5; L-PAM, 4 mg PO, days 1-10 every six weeks
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Treatment 2: Act-D, 0.01 mg/kg IV, days 1-5; L-PAM, 4 mg PO, days 1-10; Vincristine, 1 mg IV, days 1, 8, 15, 22, 29, 36, repeat every six weeks
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Treatment 3: Act-D, 0.01 mg/kg IV, days 1-5; L-PAM, 4 mg PO, days 1-10; NSC-1026, 200 mg/kg IV, days 1-6
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Treatment 4: Adriamycin, 0.4 mg/kg IV, days 1, 2, 3, 8, 9, 10, then 2XWK starting day 15 (max. 1,200 mg)
Number of subjects: 144
Study: 30503506

Group type: EXPERIMENTAL
Intervention: TMS-EEG in MDD participants
Number of subjects: 30

Group type: COMPARATOR
Intervention: TMS-EEG in healthy participants
Number of subjects: 30
Study: 28366181

Group type: EXPERIMENTAL
Intervention: ALA + quercetin (190 mg/d)
Number of subjects: 67

Group type: COMPARATOR
Intervention: ALA + placebo (3.3 g/d ALA)
Number of subjects: 67
Study: 25630055

Group type: EXPERIMENTAL
Intervention: Monoblock MAD
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Twin block MAD
Number of subjects: 45
Study: 23343489

Group type: EXPERIMENTAL
Intervention: Psychotherapy for late-life depression
Number of subjects: 22
Study: 21760724

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (400 mg PO once daily for 5 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid (875/125 mg PO twice daily for 7 days)
Number of subjects: 0
Study: 19843742

Group type: EXPERIMENTAL
Intervention: 64-MDCT with oral and IV contrast media (Group 1)
Number of subjects: 303

Group type: COMPARATOR
Intervention: 64-MDCT with IV contrast material only (Group 2)
Number of subjects: 303
Study: 17426111

Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T(3)) infusion for 24 hours after surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo infusion for 24 hours after surgery
Number of subjects: 0
Study: 15553821

Group type: EXPERIMENTAL
Intervention: Shengxuening (SXN) 0.1 g, three times per day for 30 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ferrous gluconate 0.1 g, three times per day for 30 days
Number of subjects: 100
Study: 11439409

Group type: EXPERIMENTAL
Intervention: m‐CPP (meta‐chlorophenylpiperazine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: m‐CPP
Number of subjects: 12
Study: 9800078

Group type: EXPERIMENTAL
Intervention: Groningen voice prosthesis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nijdam voice prosthesis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provox voice prosthesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Groningen, Nijdam, and Provox voice prostheses
Number of subjects: 0
Study: 7972781

Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (25 mg) and dipyridamole (200 mg) (ASAD) twice daily for 1 year
Number of subjects: 160

Group type: COMPARATOR
Intervention: Oral anticoagulants
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (25 mg) and dipyridamole (200 mg) (ASAD)
Number of subjects: 160
Study: 2685207

Group type: EXPERIMENTAL
Intervention: Nortriptyline (specific dosage and duration not mentioned)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Untreated group (no specific intervention mentioned)
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Patients receiving antidepressants at the time of assessment (specific treatment not mentioned)
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment initiated after assessment (specific treatment not mentioned)
Number of subjects: 680
Study: 48731

Group type: EXPERIMENTAL
Intervention: Increased exposure to sunlight during the hot season
Number of subjects: 91

Group type: COMPARATOR
Intervention: Cold season group (control)
Number of subjects: 91
Study: 31625835

Group type: EXPERIMENTAL
Intervention: Omr‐IgG‐am
Number of subjects: 62

Group type: COMPARATOR
Intervention: IVIG
Number of subjects: 62

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 62
Study: 28454872

Group type: EXPERIMENTAL
Intervention: Experimental group (received crash alerts)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (never received warnings)
Number of subjects: 40
Study: 25636410

Group type: EXPERIMENTAL
Intervention: Individualized homeopathy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23139093

Group type: EXPERIMENTAL
Intervention: Intermittent monitoring of ScvO2
Number of subjects: 106

Group type: COMPARATOR
Intervention: Continuous monitoring of ScvO2
Number of subjects: 106
Study: 22269198

Group type: EXPERIMENTAL
Intervention: Single session filling without calcium hydroxide medication
Number of subjects: 20

Group type: COMPARATOR
Intervention: Calcium hydroxide-based intracanal medication Calen®
Number of subjects: 20
Study: 19563586

Group type: EXPERIMENTAL
Intervention: 30 LD(50) units/kg total body weight of BoNT‐A injected into gastrocnemius muscles every 4 months
Number of subjects: 214

Group type: COMPARATOR
Intervention: 30 LD(50) units/kg total body weight of BoNT‐A injected into gastrocnemius muscles once yearly
Number of subjects: 214
Study: 18062111

Group type: EXPERIMENTAL
Intervention: Tissue-engineered mucosal graft
Number of subjects: 9

Group type: COMPARATOR
Intervention: Periosteal fenestration technique
Number of subjects: 9
Study: 12631443

Group type: EXPERIMENTAL
Intervention: Oral antioxidative treatment (Quatral) once daily for 16 weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 74
Study: 10698386

Group type: EXPERIMENTAL
Intervention: Adenosine (12 mg intravenously)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study: 9329380

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/day)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Estrogen (hormone replacement therapy)
Number of subjects: 33

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 33
Study: 7870919

Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/l)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Alcohol + Diazepam (5 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 2874958

Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clemastine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30359870

Group type: EXPERIMENTAL
Intervention: Anteroposterior (AP) shoulder joint mobilization
Number of subjects: 31

Group type: COMPARATOR
Intervention: Manual contact
Number of subjects: 31

Group type: COMPARATOR
Intervention: No-contact intervention
Number of subjects: 31
Study: 27545673

Group type: EXPERIMENTAL
Intervention: Active-approach messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active-avoidance messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Less active behavior messages
Number of subjects: 0
Study: 24964745

Group type: EXPERIMENTAL
Intervention: Global Antiphospholipid Syndrome Score (GAPSS)
Number of subjects: 51

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Increase in GAPSS
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Increase in GAPSS by 3 or more points
Number of subjects: 51
Study: 23356032

Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment lasting six months (intervention group)
Number of subjects: 0
Study: 19482961

Group type: EXPERIMENTAL
Intervention: Proximity to nutrient-dense food
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Proximity to energy-dense food
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sitting farther away from food
Number of subjects: 46
Study: 19020698

Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage supplemented by Deep Oscillation (n=11)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Manual lymphatic drainage alone (n=10)
Number of subjects: 21
Study: 15593392

Group type: EXPERIMENTAL
Intervention: Autologous transfusion (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Allogeneic transfusion (Group H)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between Group A and Group H
Number of subjects: 60
Study: 12885982

Group type: EXPERIMENTAL
Intervention: Buteyko breathing technique
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pink City Lung Exerciser (PCLE)
Number of subjects: 90

Group type: COMPARATOR
Intervention: PCLE placebo device
Number of subjects: 90
Study: 10393392

Group type: EXPERIMENTAL
Intervention: Oral isosorbide-5-mononitrate (ISMN) 50 mg once daily
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 8697554

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine alone (phase M)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Co-administration of ketamine (1.0 mg) with morphine (phase M + K)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (phase M)
Number of subjects: 0
Study: 1992660

Group type: EXPERIMENTAL
Intervention: DFO 40 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DFO 80 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DFO (both doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DFO once a week
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DFO (higher doses)
Number of subjects: 12
Study: 7045603

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (De‐Nol, Gist‐Brocades)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 30575602

Group type: EXPERIMENTAL
Intervention: At-home auditory training program for 5 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Audiobooks (active control)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Passive control (no intervention)
Number of subjects: 43
Study: 30177481

Group type: EXPERIMENTAL
Intervention: Patients in the MWP region
Number of subjects: 839

Group type: EXPERIMENTAL
Intervention: Younger patients with DM2
Number of subjects: 839

Group type: COMPARATOR
Intervention: All variables including 'GP practice'
Number of subjects: 839

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 839
Study: 26769016

Group type: EXPERIMENTAL
Intervention: 4 mL 7% hypertonic saline
Number of subjects: 132

Group type: COMPARATOR
Intervention: 0.12% saline (control)
Number of subjects: 132
Study: 24686785

Group type: EXPERIMENTAL
Intervention: Orientation judgment task with visual stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention modulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spatial and temporal proximity of stimuli
Number of subjects: 0
Study: 21603966

Group type: EXPERIMENTAL
Intervention: Clearfil S3 Bond (one-step self-etch adhesive)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Optibond FL (three-step etch-and-rinse adhesive)
Number of subjects: 26
Study: 20110538

Group type: EXPERIMENTAL
Intervention: 80 mg/day atorvastatin
Number of subjects: 4731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4731
Study: 17122083

Group type: EXPERIMENTAL
Intervention: Rosi (8 mg/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rosi (1 μM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rosi (20 mg/kg·d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rosi treatment (1 μM)
Number of subjects: 50
Study: 16275520

Group type: EXPERIMENTAL
Intervention: Echocardiographic midwall fractional shortening after CoA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cine MR midwall fractional shortening after CoA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3-dimensional MR tagging midwall circumferential shortening in CoA group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3-dimensional MR tagging midwall longitudinal shortening in CoA group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cine MR midwall shortening recalculated for through-plane motion
Number of subjects: 30
Study: 12856053

Group type: EXPERIMENTAL
Intervention: Four weeks of aminosidine (paromomycin) ointment
Number of subjects: 216

Group type: COMPARATOR
Intervention: Two weeks of aminosidine (paromomycin) ointment and two weeks of placebo
Number of subjects: 216
Study: 10625320

Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg
Number of subjects: 928

Group type: EXPERIMENTAL
Intervention: omeprazole 10 mg
Number of subjects: 928

Group type: COMPARATOR
Intervention: ranitidine 150 mg
Number of subjects: 928
Study: 8909908

Group type: COMPARATOR
Intervention: Low-intensity training
Number of subjects: 29

Group type: COMPARATOR
Intervention: High-intensity training
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control
Number of subjects: 29
Study: 1745027

Group type: EXPERIMENTAL
Intervention: Plasma exchange, prednisolone, cyclophosphamide, and azathioprine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Drug therapy only (control group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Not applicable (serum creatinine < 500 mumol/liter)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Not applicable (serum creatinine > 500 mumol/liter but not on dialysis)
Number of subjects: 48
Study: 6964655

Group type: EXPERIMENTAL
Intervention: Rayner Binkhorst pupil‐supported intraocular lens (IOL) calculated for emmetropia using biometric data
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard power +19 D IOL
Number of subjects: 200
Study: 31640891

Group type: EXPERIMENTAL
Intervention: Height (measured in quintiles or 5 cm increments)
Number of subjects: 17263
Study: 29094048

Group type: COMPARATOR
Intervention: Single-dose Praziquantel (40 mg/kg)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Double-dose Praziquantel (40 mg/kg)
Number of subjects: 431
Study: 26727115

Group type: EXPERIMENTAL
Intervention: Artificially sweetened beverages (ASB)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sugar-sweetened beverages (SSB)
Number of subjects: 31
Study: 24903351

Group type: EXPERIMENTAL
Intervention: Apple juice
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water
Number of subjects: 14